Loading…
Back To Schedule
Tuesday, March 14 • 9:45am - 10:30am
Panel: Strategies for Survival: Looking at Alternative Deal Constructs and Creative Financing to Endure Market Instability

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Feedback form is now closed.
  • How do you decide what the “right” deal structure is for the collaboration?
  • Using non-diluted funding, other non-equity financing or option-based deals to stay afloat
  • Building flexibility into the deal structure to account for uncertainty
  • Deciding whether to go the M&A route vs. alliances or product acquisition
  • Going beyond the conventional: Examples of innovative deal structures: joint ventures, subsidiary programs, royalty financing and more
  • Tips for structuring a deal that is win-win for both sides

Moderators
avatar for Mark Stead

Mark Stead

Senior Business Development Director, Exelixis, Inc.
Mark Stead, Ph.D. is Senior Business Development Director at Exelixis, Inc. In this role, he is responsible for the negotiation of partnerships and strategic transactions on behalf of Exelixis as it strives to accelerate the discovery, development and commercialization of new medicines... Read More →

Speakers
avatar for Michael Bologna

Michael Bologna

Partner, NovaQuest Capital Management
Mike Bologna, Partner at NovaQuest Capital Management, has over 20 years of experience in the biomedical industry across pharmaceuticals and health care investing. He is responsible for sourcing, negotiating, due diligence, structuring of investment opportunities, and post-close investment... Read More →
avatar for David Brower

David Brower

Chief Business Officer, Accent Therapeutics
David Brower joined Accent Therapeutics in September 2018 and serves as Chief Business Officer. David has held a number of life science business development, strategy, and investing roles prior to joining Accent. Most recently, David led the business development function for Blueprint... Read More →
avatar for Ahmed Mousa

Ahmed Mousa

Senior Vice President, Chief Business Officer and General Counsel, Pieris Pharmaceuticals
Ahmed is the Senior Vice President, Corporate Operations and General Counsel of Pieris Pharmaceuticals where he acts as site head for the company's Boston office, oversees the centralized project leadership and quality assurance functions, and leads Pieris’ intellectual property... Read More →
avatar for Ramlah Nehring, PhD

Ramlah Nehring, PhD

Head of Strategy and Transactions, Roche Diagnostics
Ramlah Nehring, Ph.D. is the Head of Strategy and Transactions at Roche Diagnostics, she is based in San Diego, California and leads a global team across APAC, North America and Europe. Her team leads deals for Roche Diagnostics across the spectrum of partnerships, licensing, and... Read More →

Tuesday March 14, 2023 9:45am - 10:30am PDT
Hyatt Centric Fisherman's Wharf San Francisco
  Business Development

Attendees (21)